American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples